HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

An enzyme-linked immunosorbent assay (ELISA) for the detection and quantification of antibodies against swine vesicular disease virus (SVDV).

Abstract
A liquid phase blocking sandwich ELISA has been compared with virus neutralisation for testing pig sera for antibodies against swine vesicular disease (SVD) virus. Highest infectivity titre of SVD virus was obtained using a multiplicity of infection of 30 pfu/cell and harvesting after 21 h. Titres obtained for 300 clinically normal animals were assessed by ELISA and 89% were found to be 1/6 or less. Results were skewed and spread up to 1/45. Comparison of known positive sera resulted in a correlation between the two methods of 0.68 and showed that a virus neutralisation titre of 1/16 was equivalent to 1/40 (log10 1.61) by ELISA. Variation in results obtained by replicate testing using ELISA and virus neutralisation was almost identical. Overlap between positive and negative sera was shown to be reduced to 1-1/2 fold in ELISA. Therefore, the ELISA correlated well with virus neutralisation and has several advantages over the latter.
AuthorsR M Armstrong, I T Barnett
JournalJournal of virological methods (J Virol Methods) Vol. 25 Issue 1 Pg. 71-9 (Jul 1989) ISSN: 0166-0934 [Print] Netherlands
PMID2778030 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Viral
Topics
  • Animals
  • Antibodies, Viral (analysis, immunology)
  • Enterovirus Infections (veterinary)
  • Enteroviruses, Porcine (growth & development, immunology)
  • Enzyme-Linked Immunosorbent Assay
  • Guinea Pigs
  • Neutralization Tests
  • Rabbits
  • Swine
  • Swine Vesicular Disease (diagnosis, microbiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: